These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20827184)

  • 1. Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.
    Pietra G; Vitale C; Pende D; Bertaina A; Moretta F; Falco M; Vacca P; Montaldo E; Cantoni C; Mingari MC; Moretta A; Locatelli F; Moretta L
    Cancer Immunol Immunother; 2016 Apr; 65(4):465-76. PubMed ID: 26289090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highlight of 2023: Unlocking the therapeutic potential of natural killer cells-advances in adaptive functions, cellular engineering and immunotherapy.
    Lam PY; Souza-Fonseca-Guimaraes F
    Immunol Cell Biol; 2024 Jul; 102(6):444-447. PubMed ID: 38693888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive cellular therapy after hematopoietic stem cell transplantation.
    Vittayawacharin P; Kongtim P; Chu Y; June CH; Bollard CM; Ciurea SO
    Am J Hematol; 2024 May; 99(5):910-921. PubMed ID: 38269484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver Transplantation.
    Ohira M; Imaoka K; Bekki T; Sato K; Imaoka Y; Nakano R; Yano T; Doskali M; Shimizu S; Chogahara I; Sato S; Nakamura M; Tanaka Y; Ohdan H
    Transplant Proc; 2024 Apr; 56(3):667-671. PubMed ID: 38326202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.
    Devine SM; Horowitz MM
    J Clin Oncol; 2021 Feb; 39(5):534-544. PubMed ID: 33434065
    [No Abstract]   [Full Text] [Related]  

  • 6. The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection.
    Rajaram S; Canaday LM; Ochayon DE; Rangel KM; Ali A; Gyurova IE; Krishnamurthy D; Fletcher JS; Reighard SD; Cox A; Weirauch MT; Kottyan LC; Deshmukh H; Zacharias WJ; Borchers MT; Waggoner SN
    Immunity; 2020 Jun; 52(6):887-889. PubMed ID: 32405233
    [No Abstract]   [Full Text] [Related]  

  • 7. Egr2 to the rescue: nanoparticles revitalize natural killer cells in the fight against cancer.
    Pfefferle A; Phuyal S; Netskar H; Malmberg KJ
    EMBO J; 2024 Jul; 43(13):2527-2529. PubMed ID: 38886578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation.
    Clausen J; Böhm A; Straßl I; Stiefel O; Buxhofer-Ausch V; Machherndl-Spandl S; König J; Schmidt S; Steitzer H; Danzer M; Kasparu H; Weltermann A; Nachbaur D
    Biomedicines; 2017 Mar; 5(2):. PubMed ID: 28536356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.
    Cichocki F; Cooley S; Davis Z; DeFor TE; Schlums H; Zhang B; Brunstein CG; Blazar BR; Wagner J; Diamond DJ; Verneris MR; Bryceson YT; Weisdorf DJ; Miller JS
    Leukemia; 2016 Feb; 30(2):456-63. PubMed ID: 26416461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation.
    Keppel MP; Yang L; Cooper MA
    J Immunol; 2013 May; 190(9):4754-62. PubMed ID: 23530145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).
    Gallez-Hawkins GM; Li X; Franck AE; Gendzekhadze K; Nakamura R; Forman SJ; Senitzer D; Zaia JA
    Hum Immunol; 2012 Nov; 73(11):1109-15. PubMed ID: 22939905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer.
    Torkelson CJ; Sweet E; Martzen MR; Sasagawa M; Wenner CA; Gay J; Putiri A; Standish LJ
    ISRN Oncol; 2012; 2012():251632. PubMed ID: 22701186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunomodulatory activity of gelatin-encapsulated Rubus coreanus Miquel nanoparticles.
    Seo YC; Choi WY; Lee CG; Cha SW; Kim YO; Kim JC; Drummen GP; Lee HY
    Int J Mol Sci; 2011; 12(12):9031-56. PubMed ID: 22272118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells and tumor control.
    Cooley S; Weisdorf DS
    Curr Opin Hematol; 2010 Nov; 17(6):514-21. PubMed ID: 20827184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Aversa F; Martelli MF; Velardi A
    Cytotherapy; 2006; 8(6):554-8. PubMed ID: 17148031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers.
    Stern M; Passweg JR; Meyer-Monard S; Esser R; Tonn T; Soerensen J; Paulussen M; Gratwohl A; Klingebiel T; Bader P; Tichelli A; Schwabe D; Koehl U
    Bone Marrow Transplant; 2013 Mar; 48(3):433-8. PubMed ID: 22941380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
    Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.